EMA Clinical Trials Map Visualizer Explained

Explore how the EMA Clinical Trials Map visualizes trial activity across Europe to support recruitment planning and site strategy decisions.

EMA Clinical Trials Map Visualizer Explained

Explore how the EMA Clinical Trials Map visualizes trial activity across Europe to support recruitment planning and site strategy decisions.
Cyntegrity logo – Risk-Based Quality Management Solutions

Seeing Clinical Trial Activity in Context

Clinical trial data is widely available, yet not always easy to interpret when geography plays a central role. Tables and spreadsheets are effective for calculations, but they often obscure spatial patterns that matter for planning and oversight.

 

The EMA Clinical Trials Map Visualizer addresses this gap by presenting European clinical trial data in a geographic format. It helps clinical operations and analytics teams understand where trials are concentrated, which regions are actively recruiting, and how competition for sites may affect feasibility and timelines.

What You Can Do With the Visualizer

Turn geographic data into operational awareness.

Explore trial distribution across Europe

View trial and site density at country, regional, and sub-regional levels to understand where research activity is concentrated.

Filter by medical condition and recruitment status

Narrow results by indication and active recruitment to assess competition, site experience, and feasibility for upcoming studies.

Support recruitment and site strategy decisions

Use geographic patterns to anticipate site availability, investigator workload, and potential overlap with other trials.

Why a map changes how data is understood

The visualizer is built on publicly available EMA clinical trial registry data. Instead of listing trials in tabular form, it displays them geographically, allowing users to see relationships between location, study volume, and recruitment activity at a glance.

 

This visual approach reduces analytical friction and supports earlier, more informed decisions—particularly when planning studies in regions with varying site capacity or competing trials.

What changes when you view trial data on a map instead of a table?
Explore how geographic context reveals patterns that are difficult to detect through spreadsheets alone.

Part of the eyesON Interactive Visualizer Series

The EMA Clinical Trials Map Visualizer is part of Cyntegrity’s eyesON series—a collection of free, interactive tools designed to make complex clinical research data easier to explore and interpret.

 

Through eyesON, Cyntegrity shares its data analytics expertise with the broader research community, helping teams build intuition around regulatory, operational, and methodological topics without adding complexity. Explore More Interactive Visualizers…

Explore The EMA Visualizer

See how other datasets can sharpen signal awareness and decision-making.

Stay Informed with Us

Risk-based quality management in 2026

Risk-based quality management in 2026: how ICH E6(R3) defines RBQM, where practice diverges, and what regulators now expect in clinical trials....
Diagram illustrating the FDA Total Product Lifecycle (TPLC) management approach for AI and machine learning devices, showing a continuous cycle of design, validation, submission, monitoring, and update.

FDA AI Guidance 2025 Interactive Visualizer

Explore how FDA’s 2025 AI guidance shapes lifecycle oversight for AI-enabled medical software through interactive regulatory scenarios....

Media Inquiries

Need a quote, speaker, or more info about Cyntegrity? Reach out directly to our media contact for timely assistance.

Let’s Talk RBQM @ SCOPE Summit! Visit us at Booth #615

Cyntegrity logo – Risk-Based Quality Management Solutions
Picture of Artem Andrianov, PhD

Artem Andrianov, PhD

CEO & Founder

Picture of Dr. Johann Proeve

Dr. Johann Proeve

Chief Scientific Officer

Picture of David Lacagnina

David Lacagnina

Chief Business Officer

Picture of Sven Cohadzic

Sven Cohadzic

Project Manager